IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.48−0.17 (-4.79%)
Close on Nov 13, 2026Market cap $25.64MP/E –Yield –
Immutep enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immutep's enterprise value was -$17.58M on Nov 11, 2026, against $251.37M a year earlier. Over the last 5 years it ranged from -$22.30M to $371.41M, with a median of $112.02M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$17.58M | -104.7% |
| 2025 | Dec 31, 2025 | $371.41M | +131.3% |
| 2024 | Dec 31, 2024 | $160.56M | +23.6% |
| 2023 | Dec 29, 2023 | $129.91M | +38.0% |
| 2022 | Dec 30, 2022 | $94.13M | -37.7% |
| 2021 | Dec 31, 2021 | $151.15M | +38.2% |
| 2020 | Dec 31, 2020 | $109.35M | +116.8% |
| 2019 | Dec 31, 2019 | $50.43M | +48.0% |
| 2018 | Dec 31, 2018 | $34.08M | +15.1% |
| 2017 | Dec 29, 2017 | $29.61M | -25.6% |
| 2016 | Dec 30, 2016 | $39.80M | – |
See a number that looks wrong?